# Early Detection of Five Common Cancers Using the ctDNA Analysing Test

> **NCT05227261** · — · COMPLETED · sponsor: **Gene Solutions** · enrollment: 9057 (actual)

## Conditions studied

- Cancer, Lung
- Cancer, Breast
- Cancer Liver
- Cancer, Colorectal
- Liquid Biopsy
- Circulating Tumour DNA
- Cancer, Gastric

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05227261
- **Lead sponsor:** Gene Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-10
- **Primary completion:** 2023-04-10
- **Final completion:** 2024-04-10
- **Target enrollment:** 9057 (ACTUAL)
- **Last updated:** 2025-02-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05227261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05227261, "Early Detection of Five Common Cancers Using the ctDNA Analysing Test". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05227261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*